HLA-G expression: Immune privilege for tumour cells?

Seminars in Cancer Biology

Volumn 9, Issue 1, 1999, Pages 27-36

  Cabestre, Francisco Adrian ^a   Lefebvre, Sophie ^a   Moreau, Philippe ^a   Rouas Freiss, Nathalie ^a   Dausset, Jean ^b   Carosella, Edgardo D ^a   Paul, Pascale ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b FONDATION JEAN DAUSSET CEPH   (France)

Author keywords

HLA G; Immune tolerance; Melanoma; Tumour immune escape

Indexed keywords

CELL RECEPTOR; HLA ANTIGEN CLASS 1; HLA G ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; DOWN REGULATION; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOSURVEILLANCE; MELANOMA CELL; NATURAL KILLER CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR BIOPSY; TUMOR CELL;

EID: 0033081370     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1998.0104     Document Type: Article

References (49)

1. Pardoll DM (1998) Cancer vaccines. Nature Med 4:525-531
2. Bona CA, Casares S, Brumeanu TD (1998) Towards development of T-cell vaccines. Immunol Today 19:126-132
3. Ferrone S, Marincola FM (1995) Loss of HLA class I antigens by melanoma cells: Molecular mechanisms, functional significance and clinical relevance. Immunol Today 16:487-494
4. Garrido F, Ruiz-Cabello F, Cabrera T, Pérez-Villar JJ, López-Botet M, Duggan-Keen M, Stern PL (1997) Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today 18:89-95
5. Carosella ED, Rouas-Freiss N, Paul P, Dausset J (1999). HLA-G: A tolerance molecule from the major histocompatibility complex. Immunol Today 20:60-62
6. Rouas-Freiss N, Marchal-Bras Gonzalves R, Menier C, Dausset J, Carosella ED (1997) Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 94: 11520-11525
7. King A, Gardner L, Loke YW (1996) Human decidual leukocytes do not proliferate in response to either extravillous trophoblast or allogeneic peripheral blood lymphocytes. J Reprod Immunol 30:67-74
8. Ohlsson R (1989) Growth factors, protooncogenes and human placental development. Cell Differ Dev 28:1-15
9. Strickland S, Richards W.G. (1992) Invasion of the trophoblasts. Cell 71:355-357
10. Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M., Ginzburg Y, Reich R, Vlodavsky I, Bar-Shavit R (1998) Thrombin receptor overexpression in malignant and physiological invasion processes. Nature Med 4:909-914
11. Blaschitz A, Lenfant F, Mallet V, Hartmann M, Bensussan A, Geraghty DE, Le Bouteiller P, Dohr G (1997) Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur J Immunol 27:3380-3388
12. DePlaen E, Naerhuyzen B, De Smet C, Szikora JP, Boon T (1997) Alternative promoters of gene MAGE-4. Genomics 40:305-313
13. Shih IM, Kurman RJ (1996) Expression of melanoma cell adhesion molecule in intermediate trophoblast. Lab Invest 75:377-388
14. Adrián Cabestré F, Moreau P, Riteau B, Ibrahim EC, Le Danff C, Dausset J, Rouas-Freiss N, Carosella ED, Paul P (1998) HLA-G expression in human melanoma cells: Protection from NK cytolysis. J Reprod Immunol, in press
15. Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, Le Gal FA, Avril MF, Dausset J, Guillet JG, Carosella ED (1998) HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 95:4510-4515
16. Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED (1997) The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci USA 94:5249-5254
17. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391:795-799
18. Lefebvre S, Moreau P, Guiard V, Ibrahim EC, Adrián Cabestré F, Menier C, Dausset J, Carosella ED, Paul P (1998) Molecular mechanisms controlling constitutive and IFNγ-inducible HLA-G expression in various cell types. J Reprod Immunol, in press
19. Amiot L, Onno M, Drénou B, Monvoisin C, Fauchet R (1998) HLA-G expression in normal and malignant hematopoietic cells. Hum Immunol 59:524-528
20. Puppo F, Indiveri F, Scudeletti M, Ferrone S (1997) Soluble HLA antigens: New roles and uses. Immunol Today 18:154-155
21. Carbone E, Terrazzano G, Colonna M, Tuosto L, Piccolella E, Franksson L, Pérez-Villar JJ, Fontana S, Kärre K, Zappacosta S (1996) Natural killer clones recognize specific soluble HLA class I molecules. Eur J Immunol 26:683-689
22. Zavazava N, Krönke M (1996) Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nature Med 2:1005-1010
23. Fujii T, Ishitani A, Geraghty DE (1994) A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 153:5516-5524
24. Moreau P, Carosella E, Teyssier M, Prost S, Gluckman E, Dausset J, Kirszenbaum M (1995) Soluble HLA-G molecule. An alternatively spliced HLA-G mRNA form candidate to encode it in peripheral blood mononuclear cells and human trophoblasts. Hum Immunol 43:231-236
25. Chu W, Fant ME, Geraghty D, Hunt J (1998) Soluble HLA-G in human placentas: Synthesis in trophoblasts and interferon-g-activated macrophages but not placental fibroblasts. Hum Immunol 59:435-442
26. Houlihan JM, Biro PA, Harper HM, Jenkinson HJ, Holmes CH (1995) The human amnion is a site of MHC class Ib expression: Evidence for the expression of HLA-E and HLA-G. J Immunol 154:5665-5674
27. Lee N, Malacko AR, Ishitani A, Chen MC, Bajorath J, Marquardt H, Geraghty DE (1995) The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3:591-600
28. Diehl M, Munz C, Keilholz W, Stevanovic S, Holmes N, Loke YW, Rammensee HG (1996) Nonclassical HLA-G molecules are classical peptide presenters. Curr Biol 6:305-314
29. Riteau B, Menier C, Khalil-Daher I, Sedlik C, Dausset J, Rouas-Freiss N, Carosella ED (1998) HLA-G inhibits the allogenic proliferative response. J Reprod Immunol, in press
30. Tartour E, Fridman WH (1998) Cytokines and cancer. Int Rev Immunol 16:683-704
31. Chen L, McGowan P, Ashe S, Johnson J, Li Y, Hellström I, Hellström Ke (1994) Tumor immunogenicity determines the effect of B7 costimulation on T-cell-mediated tumor immunity. J Exp Med 179:523
32. Walker PR, Saas P, Dietrich PY (1998) Tumor expression of Fas ligand (CD95L) and the consequences. Curr Opin Immunol 10:564-572
33. 2-microglobulin-deficient melanoma cells: Implications for cancer immunotherapy. Proc Natl Acad Sci USA 94:13140-13145
34. Pende D, Accame L, Pareti L, Mazzocchi A, Moretta A, Parmiani G, Moretta L (1998) The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles. Eur J Immunol 28:2384-2394
35. O'Callaghan C, Bell J (1998). Structure and functions of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol Rev 163:129-138
36. Khalil-Daher I, Riteau B, Menier C, Sedlik C, Paul P, Dausset J, Carosella ED, Rouas-Freiss N (1998) Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself. J Reprod Immunol (in press)
37. Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu M (1997) A novel Ig superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273-283
38. Colonna M, Navarro F, Bellón T, Llano M, García P, Samaridis J, Angman L, Cella M, López-Botet M (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186:1809-1818
39. Cantoni C, Verdiani S, Falco M, Pessino A, Cilli M, Conte R, Pende D, Ponte M, Mikaelsson MS, Moretta L, Biassoni R (1998) P49, a putative HLA class I-specific inhibitory NK receptor belonging to the Ig superfamily. Eur J Immunol 28:1980-1990
40. Mandelboim O, Pazmany L, Davis DM, Valés-Gómez M, Reyburn HT, Rybalov B, Strominger JL (1997) Multiple receptors for HLA-G on human natural killer cells. Proc Natl Acad Sci USA 94:14666-14670
41. Llano M, Lee N, Navarro F, Garcia P, Albar JP, Geraghty DE, Lopez-Botet M (1998) HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: Preferential response to an HLA-G-derived nonamer. Eur J Immunol 28:2854-2863
42. Leibson PJ (1998) Cytotoxic lymphocyte recognition of HLA-E: Utilizing a non classical window to peer into classical MHC. Immunity 9:289-294
43. Mingari MC, Moretta A, Moretta L (1998) Regulation of KIR expression in human T cells: A safety mechanism that may impair protective T-cell responses. Immunol Today 19:153-154
44. Ikeda H, Lethé B, Lehmann F, Van Baren N, Baurain J-F, DeSmet C, Chambost H, Vitale M, Moretta A, Boon T, Coulie P (1997) Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6:199-208
45. Bakker ABH, Phillips JH, Figdor CG, Lanier LL (1998) Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, γδ T cells, and antigen-specific CTL. J Immunol 160:5239-5245
46. Barzegar C, Meazza R, Pereno R, Pottin-Clemenceau C, Scudeletti M, D. B-B, Doucet C, Taoufik Y, Ritz J, Musselli C, Mishal Z, Jasmin C, Indiveri F, Ferrini S, Azzarone B (1998) IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops. Oncogene 16:2503-2512
47. Chen Q, Daniel V, Maher D, Hersey P (1994) Production of IL-10 by melanoma cells: Examination of its role in immuno-suppression mediated by melanoma. Int J Cancer 56:755-760
48. Colonna M, Samaridis J, Cella M, Angman L, Allen RL, O'Callaghan C, Dunbar R, Ogg GS, Cerundolo V, Rolink A (1998) Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 160:3096-3100
49. Enk AH, Jonuleit H, Saloga J, Knop J (1997) Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer 73:309-316